Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06210035 · ClinicalTrials.gov registry record · NA

Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
94
Enrollment target

NCT06210035 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 94 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06210035, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target

Study Summary

In the current study, we will examine how two types of concentration meditation practices affect plasma biomarkers of Alzheimer's Disease (AD). We will also examine the effects of the two types of meditation practices on emotional well-being and episodic memory. Healthy adults aged 18-35 who meet all eligibility criteria will be invited to this study. Participants will be asked to engage in one week of daily meditation practice or no-intervention control task at home. They will also be asked to visit the lab twice, once before and once after the intervention, to provide blood samples to assess plasma biomarkers of AD and to complete emotion questionnaires and a memory test.

Interventions

  • BEHAVIORAL Belly-focus meditation
  • BEHAVIORAL Belly-focus meditation with slow breathing

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2024-01-29
Est. Completion 2024-05-03
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT06210035

The ClinicalTrials.gov registry entry for NCT06210035 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Belly-focus meditation is the first listed.

NCT06210035 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06210035 about?

NCT06210035 is a clinical study titled "Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease". In the current study, we will examine how two types of concentration meditation practices affect plasma biomarkers of Alzheimer's Disease (AD). We will also examine the effects of the two types of meditation practices on emotional well-being and episodic memory. Healthy adults aged 18-35 who meet al...

What is the current status of trial NCT06210035?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2024-01-29. Estimated completion is 2024-05-03.

What interventions are being tested in trial NCT06210035?

The interventions under investigation include: Belly-focus meditation (BEHAVIORAL), Belly-focus meditation with slow breathing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06210035?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.